Elecsys GDF-15

From the manufacturer

Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.

• Intended useImmunoassay for the in vitro quantitative determination of Growth Differentiation Factor‑15 (GDF‑15) in human serum and plasma.The Elecsys GDF‑15 assay is intended as an aid in risk stratification of patients with Acute Coronary Syndrome (ACS) or Chronic Heart Failure (CHF).

  Roche DiagnosticsProduct TypeManufacturer Page2026-10-06

• The Elecsys GDF‑15 assay is intended as an aid in risk prediction of major bleeding events of patients with Atrial Fibrillation (AF).The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.

  Roche DiagnosticsTechnology PlatformManufacturer Page2026-10-06